Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
973
Views
34
CrossRef citations to date
0
Altmetric
Non-neutralizing protective antibodies

The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins

Daan de GouwLaboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands;Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands
,
Diego O SerraNijmegen Centre for Mitochondrial Disorders, Department of Laboratory Medicine, Radboud Proteomics Centre, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands
,
Marien I de JongeLaboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands;Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands
,
Peter WM HermansLaboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands;Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands
,
Hans JCT WesselsNetherlands Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven 3720 BA, The Netherlands
,
Aldert ZomerLaboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands;Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands
,
Osvaldo M YantornoNijmegen Centre for Mitochondrial Disorders, Department of Laboratory Medicine, Radboud Proteomics Centre, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands
,
Dimitri A DiavatopoulosLaboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands;Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands
&
Frits R MooiLaboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands;Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands;Facultad de Ciencias Exactas, Centro de Investigación y Desarrollo en Fermentaciones Industriales (CINDEFI), CONICET-CCT-La Plata, Universidad Nacional de La Plata, La Plata B1900 ASH, ArgentinaCorrespondence[email protected]
 show all
Pages 1-9 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Stocks P, Kam MN.On the epidemiology of pertussis cough in London. J Hyg1932;32: 582–619.
  • Campbell P, McIntyre P, Quinn H, Hueston L, Gilbert GL, McVernon J.Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PloS One2012;7: e35874.
  • de Greeff SC, de Melker HE, van Gageldonk PG et al.Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PloS One2010;5: e14183.
  • de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M.The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect2006;53: 106–113.
  • Ward JI, Cherry JD, Chang SJ et al.Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis2006;43: 151–157.
  • Black RE, Cousens S, Johnson HL et al.Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet2010;375: 1969–1987.
  • Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R.Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med2012;367: 1012–1019.
  • Witt MA, Katz PH, Witt DJ.Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis2012;54: 1730–1735.
  • Warfel JM, Zimmerman LI, Merkel TJ.Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA2014;111: 787–792.
  • de Gouw D, Hermans PW, Bootsma HJ et al.Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally. PloS One2014;9: e84523.
  • Mooi FR, van Loo IH, van Gent M et al.Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis2009;15: 1206–1213.
  • Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q.Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol2012;19: 1703–1704.
  • Otsuka N, Han HJ, Toyoizumi-Ajisaka H et al.Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PloS One2012;7: e31985.
  • Pawloski LC, Queenan AM, Cassiday PK et al.Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US. Clin Vaccine Immunol2014;21: 119–125.
  • Conover MS, Mishra M, Deora R.Extracellular DNA is essential for maintaining Bordetella biofilm integrity on abiotic surfaces and in the upper respiratory tract of mice. PloS One2011;6: e16861.
  • Sloan GP, Love CF, Sukumar N, Mishra M, Deora R.The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract. J Bacteriol2007;189: 8270–8276.
  • Conover MS, Sloan GP, Love CF, Sukumar N, Deora R.The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesin. Mol Microbiol2010;77: 1439–1455.
  • Serra DO, Conover MS, Arnal L et al.FHA-mediated cell-substrate and cell-cell adhesions are critical for Bordetella pertussis biofilm formation on abiotic surfaces and in the mouse nose and the trachea. PloS One2011;6: e28811.
  • Fux CA, Costerton JW, Stewart PS, Stoodley P.Survival strategies of infectious biofilms. Trends Microbiol2005;13: 34–40.
  • Serra DO, Lucking G, Weiland F et al.Proteome approaches combined with Fourier transform infrared spectroscopy revealed a distinctive biofilm physiology in Bordetella pertussis. Proteomics2008;8: 4995–5010.
  • Decker KB, James TD, Stibitz S, Hinton DM.The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA. Microbiology2012;158: 1665–1676.
  • Irie Y, Mattoo S, Yuk MH.The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica. J Bacteriol2004;186: 5692–5698.
  • Stockbauer KE, Fuchslocher B, Miller JF, Cotter PA.Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein. Mol Microbiol2001;39: 65–78.
  • Vergara-Irigaray N, Chavarri-Martinez A, Rodriguez-Cuesta J, Miller JF, Cotter PA, Martinez de Tejada G.Evaluation of the role of the Bvg intermediate phase in Bordetella pertussis during experimental respiratory infection. Infect Immun2005;73: 748–760.
  • Martinez de Tejada G, Cotter PA, Heininger U et al.Neither the Bvg-phase nor the vrg6 locus of Bordetella pertussis is required for respiratory infection in mice. Infect Immun1998;66: 2762–2768.
  • Thalen M, van den IJssel J, Jiskoot W et al.Rational medium design for Bordetella pertussis: basic metabolism. J Biotechnol1999;75: 147–159.
  • Hijnen M, van Gageldonk PG, Berbers GA, van Woerkom T, Mooi FR.The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli. Protein Expr Purif2005;41: 106–112.
  • Pink M, Verma N, Rettenmeier AW, Schmitz-Spanke S.CBB staining protocol with higher sensitivity and mass spectrometric compatibility. Electrophoresis2010;31: 593–598.
  • Cron LE, Stol K, Burghout P et al.Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease. Infect Immun2011;79: 3697–3710.
  • Livak KJ, Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta CT) method. Methods2001;25: 402–408.
  • Abdillahi H, Poolman JT.Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J Med Microbiol1988;26: 177–180.
  • Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS.The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun2010;78: 704–715.
  • Mooi FR, Van Der Maas NA, De Melker HE.Pertussis resurgence: waning immunity and pathogen adaptation—two sides of the same coin. Epidemiol Infect2014;142: 685–694.
  • Bordier C.Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem1981;256: 1604–1607.
  • Parkhill J, Sebaihia M, Preston A et al.Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet2003;35: 32–40.
  • Tsou CC, Tsai CF, Tsui YH et al.IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol Cell Proteomics2010;9: 131–144.
  • Ishihama Y, Oda Y, Tabata T et al.Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics2005;4: 1265–1272.
  • Weatherly DB, Atwood JA 3rd, Minning TA, Cavola C, Tarleton RL, Orlando R.A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results. Mol Cell Proteomics2005;4: 762–772.
  • Yu NY, Wagner JR, Laird MR et al.PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics2010;26: 1608–1615.
  • Neo Y, Li R, Howe J et al.Evidence for an intact polysaccharide capsule in Bordetella pertussis. Microbes Infect2010;12: 238–245.
  • Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF.A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens. Vaccine2013;31: 3732–3738.
  • Pulendran B, Ahmed R.Immunological mechanisms of vaccination. Nat Immunol2011;12: 509–517.
  • Rodriguez ME, Hellwig SM, Hozbor DF, Leusen J, van der Pol WL, van de Winkel JG.Fc receptor-mediated immunity against Bordetella pertussis. J Immunol2001;167: 6545–6551.
  • Hazenbos WL, Heijnen IA, Meyer D et al.Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol1998;161: 3026–3032.
  • Digiandomenico A, Warrener P, Hamilton M et al.Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening. J Exp Med2012;209: 1273–1287.
  • Stewart PS, Franklin MJ.Physiological heterogeneity in biofilms. Nat Rev Microbiol2008;6: 199–210.
  • Oosthuizen MC, Steyn B, Theron J et al.Proteomic analysis reveals differential protein expression by Bacillus cereus during biofilm formation. Appl Environ Microbiol2002;68: 2770–2780.
  • Fontaine MC, Baird G, Connor KM, Rudge K, Sales J, Donachie W.Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis. Vaccine2006;24: 5986–5996.
  • Cucarella C, Solano C, Valle J, Amorena B, Lasa I, Penades JR.Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol2001;183: 2888–2896.
  • Loehfelm TW, Luke NR, Campagnari AA.Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol2008;190: 1036–1044.
  • Lasa I, Penades JR.Bap: a family of surface proteins involved in biofilm formation. Res Microbiol2006;157: 99–107.
  • Fattahian Y, Rasooli I, Mousavi Gargari SL, Rahbar MR, Darvish Alipour Astaneh S, Amani J.Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog2011;51: 402–406.
  • Bart MJ, Harris SR, Advani A et al.Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. mBio2014;5: e01074.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.